An in vitro long-term study on human primary GH secreting pituitary tumor cells found a dose-dependent inhibition of GH release after incubation with OCT for periods ranging from 4 days up to 3 weeks, and a parallel increase in the intracellular GH levels and GH mRNA expression [51]. This evidence concerns the gene GH1 and pituitary tumor.